Algo version: 0.98b
IBRX is listed at the NASDAQ Exchange
IBRX [IBRX]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is IBRX stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for ImmunityBio, Inc. 10 years ago, but if you had invested on Tuesday 28th of July 2015 when the price was $34.64, you would have made a loss of $-31.26 per share or -90.24%

Yes, the average daily trading liquidity for ImmunityBio, Inc. is $35.71 million. You should therefore be able to get in and out of your positions relatively fast.

ImmunityBio, Inc. has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for ImmunityBio, Inc. to be high [1 out of 1]